<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MessagingLab &#187; Interviews</title>
	<atom:link href="http://www.messaginglab.com/category/interviews/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.messaginglab.com</link>
	<description>Karl Schmieder Markets Disruptive Technologies</description>
	<lastBuildDate>Thu, 19 Jan 2012 13:25:36 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Life Science Leader: Electronic Procurement Saves Biopharm/Medtech Companies Time</title>
		<link>http://www.messaginglab.com/2012/01/life-science-leader-electronic-procurement-saves-biopharmmedtech-companies-time/</link>
		<comments>http://www.messaginglab.com/2012/01/life-science-leader-electronic-procurement-saves-biopharmmedtech-companies-time/#comments</comments>
		<pubDate>Thu, 19 Jan 2012 13:17:51 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Global Biotechnology]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Productivity]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1168</guid>
		<description><![CDATA[It&#8217;s 2012 and many of us have used Amazon.com and Zappos.com (and use them regularly). It might surprise you to learn that many biotech, pharmaceutical, and medical device companies still use paper-based procurement systems. That means staff searches through stacks of catalogues or visit multiple websites for the products they need.
It doesn&#8217;t have to be [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2012/01/life-science-leader-electronic-procurement-saves-biopharmmedtech-companies-time/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Can Strategic Outsourcing Drive Innovation?</title>
		<link>http://www.messaginglab.com/2011/06/can-strategic-outsourcing-drive-innovation/</link>
		<comments>http://www.messaginglab.com/2011/06/can-strategic-outsourcing-drive-innovation/#comments</comments>
		<pubDate>Fri, 10 Jun 2011 20:36:44 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Global Biotechnology]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharma]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1135</guid>
		<description><![CDATA[My article on how developing a strategic partnership with a clinical research organization (CRO) can drive innovation just went live over at Life Science Leader.
During the past decade, one of the most significant trends in biopharmaceutical industry has been the evolution of outsourcing relationships. The  business relationships between biopharmaceutical companies and CROs has moved [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2011/06/can-strategic-outsourcing-drive-innovation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Jeff Tangney&#8217;s Doximity is a Private Physician Network</title>
		<link>http://www.messaginglab.com/2011/06/jeff-tangneys-doximity-is-a-private-physician-network/</link>
		<comments>http://www.messaginglab.com/2011/06/jeff-tangneys-doximity-is-a-private-physician-network/#comments</comments>
		<pubDate>Wed, 08 Jun 2011 20:20:07 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Social Media]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1127</guid>
		<description><![CDATA[I just interviewed Jeff Tangney, the co-founder and C.E.O. (and co-founder of Epocrates) of the private physician network, Doximity. It&#8217;s a different take on social media for physicians and a great example of how social media is changing the practice of medicine. According to Jeff:
Doximity helps [doctors] find precision referrals. One-third of our users share [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2011/06/jeff-tangneys-doximity-is-a-private-physician-network/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lance Hill&#8217;s Within3 Is Much More than a MD-Facing Social Media Site</title>
		<link>http://www.messaginglab.com/2011/03/lance-hills-within3-is-much-more-than-a-md-facing-social-media-site/</link>
		<comments>http://www.messaginglab.com/2011/03/lance-hills-within3-is-much-more-than-a-md-facing-social-media-site/#comments</comments>
		<pubDate>Tue, 01 Mar 2011 14:57:38 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Social Media]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1119</guid>
		<description><![CDATA[Within3 has a unique model when it comes to social media for physicians. The site:
focuses exclusively on helping health and life science organizations  create powerful, online venues that improve the way they collaborate and  communicate with health professionals
Over at Bridge 6, I interviewed Lance Hill, the C.E.O. Read Part 1, here.
]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2011/03/lance-hills-within3-is-much-more-than-a-md-facing-social-media-site/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Who is Cliff Mintz? And, Why Should You Care?</title>
		<link>http://www.messaginglab.com/2011/02/who-is-cliff-mintz-and-why-should-you-care/</link>
		<comments>http://www.messaginglab.com/2011/02/who-is-cliff-mintz-and-why-should-you-care/#comments</comments>
		<pubDate>Tue, 01 Feb 2011 14:53:31 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Branding Yourself]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Social Media]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1117</guid>
		<description><![CDATA[Cliff Mintz is the founder of BioCrowd, one of the largest, and most dynamic social networks for biotech researchers. (He&#8217;s also a kick-ass writer and a major contributor over at Life Science Leader &#8211; here&#8217;s his interview with Craig Venter). As part of my series on professional-facing social media sites, I interviewed Cliff over at [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2011/02/who-is-cliff-mintz-and-why-should-you-care/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Does it Takes to Succees as a Bioentrepeneur?</title>
		<link>http://www.messaginglab.com/2010/08/what-does-it-takes-to-succees-as-a-bioentrepeneur/</link>
		<comments>http://www.messaginglab.com/2010/08/what-does-it-takes-to-succees-as-a-bioentrepeneur/#comments</comments>
		<pubDate>Sat, 28 Aug 2010 14:38:16 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Interviews]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=1078</guid>
		<description><![CDATA[Life Science Leader just published my series of interviews with 3 bioentrepreneurs &#8211; Jim Chinitz of Population Diagnostics, Craig Shimasaki of BioSource Consulting and Stan Yakatan of Katan Associates. It was great fun to interview each bio-entrepreneur. Here&#8217;s a couple of key quotes:
Chinitz: The challenge&#8230; is how will you communicate your story? Will you  [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2010/08/what-does-it-takes-to-succees-as-a-bioentrepeneur/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview: Steve Woodruff, Impactiviti &#8211; Part 2</title>
		<link>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti-part-2/</link>
		<comments>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti-part-2/#comments</comments>
		<pubDate>Tue, 25 May 2010 13:38:42 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Social Media]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=955</guid>
		<description><![CDATA[This is Part 2 of my interview with Steve Woodruff of Impactiviti. For Part 1, click here.
SCHMIEDER:At the end of last year, the FDA had their meeting on social media, yet they didn’t issue guidelines and it seems like those guidelines will be a long time in coming. How does that play into pharma’s use [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti-part-2/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Interview: Steve Woodruff, Impactiviti</title>
		<link>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti/</link>
		<comments>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti/#comments</comments>
		<pubDate>Fri, 21 May 2010 20:49:43 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Social Media]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=929</guid>
		<description><![CDATA[As I&#8217;ve written before, I’ve started a series interviews with entrepreneurs in the life sciences and biotechnology industries, and individuals doing great things in marketing and branding that could be applied to biotech, the life sciences and pharmaceutical companies. The following interview is with Steve Woodruff, founder and president of Impactiviti.
Steve has been very involved [...]]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2010/05/interview-steve-woodruff-impactiviti/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		</item>
		<item>
		<title>The Future Looks More bioSynthetic Every Single Day ;-)</title>
		<link>http://www.messaginglab.com/2010/05/the-future-looks-more-biosynthetic-every-single-day/</link>
		<comments>http://www.messaginglab.com/2010/05/the-future-looks-more-biosynthetic-every-single-day/#comments</comments>
		<pubDate>Fri, 21 May 2010 15:07:48 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[BioHacking/DIYbio]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Science Fiction = Science Fact]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=946</guid>
		<description><![CDATA[Here&#8217;s Craig Ventner talking about the creation of the first synthetic cell.




Correct me if I&#8217;m wrong but didn&#8217;t Ventner &#38; Co. make a similar announcement a few months back? Here&#8217;s Ventner&#8217;s TED talk from a few months back.

]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2010/05/the-future-looks-more-biosynthetic-every-single-day/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Interview: Jeff Boily, BIOWIZARD &#8211; Part 2</title>
		<link>http://www.messaginglab.com/2010/03/interview-jeff-boily-biowizard-part-2/</link>
		<comments>http://www.messaginglab.com/2010/03/interview-jeff-boily-biowizard-part-2/#comments</comments>
		<pubDate>Thu, 25 Mar 2010 20:29:27 +0000</pubDate>
		<dc:creator>Karl Schmieder</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Entrepreneurship]]></category>
		<category><![CDATA[Global Biotechnology]]></category>
		<category><![CDATA[Interviews]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Productivity]]></category>

		<guid isPermaLink="false">http://www.messaginglab.com/?p=835</guid>
		<description><![CDATA[Information is critical to sophisticated life sciences researchers. They like to search for information, find what they’re looking for and move on.  They’re not shopping...  They’re looking for tools that save them time yet deliver very specific results. - Jeff Boily, BioWizard]]></description>
		<wfw:commentRss>http://www.messaginglab.com/2010/03/interview-jeff-boily-biowizard-part-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

